Cargando…
Shifting the paradigms for tumor suppression: lessons from the p53 field
The TP53 gene continues to hold distinction as the most frequently mutated gene in cancer. Since its discovery in 1979, hundreds of research groups have devoted their efforts toward understanding why this gene is so frequently selected against by tumors, with the hopes of harnessing this information...
Autores principales: | Barnoud, Thibaut, Indeglia, Alexandra, Murphy, Maureen E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238873/ https://www.ncbi.nlm.nih.gov/pubmed/34103683 http://dx.doi.org/10.1038/s41388-021-01852-z |
Ejemplares similares
-
The p53 Tumor Suppressor in the Control of Metabolism and Ferroptosis
por: Gnanapradeepan, Keerthana, et al.
Publicado: (2018) -
PLTP is a p53 target gene with roles in cancer growth suppression and ferroptosis
por: Gnanapradeepan, Keerthana, et al.
Publicado: (2022) -
Tumor cells containing the African-Centric S47 variant of TP53 show increased Warburg metabolism
por: Barnoud, Thibaut, et al.
Publicado: (2019) -
An African-Specific Variant of TP53 Reveals PADI4 as a Regulator of p53-Mediated Tumor Suppression
por: Indeglia, Alexandra, et al.
Publicado: (2023) -
Common genetic variants in the TP53 pathway and their impact on cancer
por: Barnoud, Thibaut, et al.
Publicado: (2019)